Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that a study published in The Cochrane Collaboration®1 concluded that non-removable, pressure-relieving casts, or total contact casts (TCC), are more effective in healing diabetes-related plantar foot ulcers than removable casts or dressings alone. Derma Sciences is the leading manufacturer and marketer of total contact casting systems, including the technologically innovative TCC-EZ®. The Cochrane Collaboration is a group of more than 28,000 healthcare specialists who systematically review randomized trials of the effects of prevention, treatment and rehabilitation as well as health systems interventions.
Help employers find you! Check out all the jobs and post your resume.
